Compare GRFS & OMAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GRFS | OMAB |
|---|---|---|
| Founded | 1940 | 1998 |
| Country | Spain | Mexico |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Aerospace |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 5.2B |
| IPO Year | 2006 | 2006 |
| Metric | GRFS | OMAB |
|---|---|---|
| Price | $9.02 | $114.36 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 4 |
| Target Price | $10.15 | ★ $102.50 |
| AVG Volume (30 Days) | ★ 551.2K | 68.0K |
| Earning Date | 01-01-0001 | 10-24-2025 |
| Dividend Yield | 1.58% | ★ 3.82% |
| EPS Growth | N/A | ★ 6.38 |
| EPS | 0.64 | ★ 0.75 |
| Revenue | ★ $8,821,017,248.00 | $870,458,176.00 |
| Revenue This Year | $5.36 | $3.46 |
| Revenue Next Year | $5.15 | $12.24 |
| P/E Ratio | ★ $17.99 | $18.86 |
| Revenue Growth | 7.31 | ★ 8.86 |
| 52 Week Low | $6.19 | $67.61 |
| 52 Week High | $11.14 | $116.26 |
| Indicator | GRFS | OMAB |
|---|---|---|
| Relative Strength Index (RSI) | 53.16 | 66.20 |
| Support Level | $8.69 | $104.39 |
| Resistance Level | $9.22 | $108.94 |
| Average True Range (ATR) | 0.18 | 3.35 |
| MACD | 0.03 | 0.75 |
| Stochastic Oscillator | 64.15 | 89.96 |
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.
Grupo Aeroportuario del Centro Norte SAB de CV operates airports in the central region of Mexico. The airport is in Monterrey, which serves nearly half of the company's total passengers. In addition, the company manages two hotels and one industrial park. Its reportable segments include its airports, the Terminal 2 NH Collection Hotel, the Hilton Garden Inn Hotel and the OMA-VYNMSA Industrial Park, individually, and information about its holding company and other companies is combined in the Others.